Promoting and facilitating strategies to improve cardiovascular health worldwide

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



ISCP Past President Prof Martinez speaks at the AHA Scientific Sessions

Posted on November 28, 2019

Prof Martinez participated as speaker in the recent AHA meeting in Philadelphia. He presented “Efficacy and safety of dapagliflozin in HFrEF according... more

Top news from AHA: ISCHEMIA, dapagliflozin for HF, gout drug post-MI

Posted on December 14, 2019

Healio and Cardiology Today reported live from the American Heart Association Scientific Sessions in Philadelphia, bringing readers the latest research and breaking... more

FDA approves CV event risk reduction indication for icosapent ethyl

Posted on December 13, 2019

The FDA on Friday approved the use of icosapent ethyl as an adjunctive therapy to reduce the risk of cardiovascular events among... more

EXCEL trial leadership responds to claims of improper conduct

Posted on December 13, 2019

Editor’s Note: The following is a response written by the EXCEL trial leadership to claims of improper conduct of the trial, as... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  •  Augusto Gallino


    Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX (more…) more

  •  Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  •  Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  •  Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more